• Home
  • Pharmaceuticals and Healthcare
T Cell Surface Glycoprotein CD4 Market, Global Outlook and Forecast 2022-2028

T Cell Surface Glycoprotein CD4 Market, Global Outlook and Forecast 2022-2028

Report Code: KNJ1281628 | No. of Pages: 74 | Category: Pharmaceuticals and Healthcare
Publisher: Market Monitor Global | Date of Publish: Apr-2022 
This report contains market size and forecasts of T Cell Surface Glycoprotein CD4 in global, including the following market information:
Global T Cell Surface Glycoprotein CD4 Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global T Cell Surface Glycoprotein CD4 Market Sales, 2017-2022, 2023-2028, (K Pcs)
Global top five T Cell Surface Glycoprotein CD4 companies in 2021 (%)
The global T Cell Surface Glycoprotein CD4 market was valued at  million in 2021 and is projected to reach US$  million by 2028, at a CAGR of  % during the forecast period.
The U.S. Market is Estimated at $  Million in 2021, While China is Forecast to Reach $  Million by 2028.
Forigerimod Acetate Segment to Reach $  Million by 2028, with a % CAGR in next six years.
The global key manufacturers of T Cell Surface Glycoprotein CD4 include Biotest AG, Bristol-Myers Squibb Co, CEL-SCI Corp, Fountain Biopharma Inc, Immupharma Plc, Sanofi, TaiMed Biologics Inc and United Biomedical Inc, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the T Cell Surface Glycoprotein CD4 manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global T Cell Surface Glycoprotein CD4 Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)
Global T Cell Surface Glycoprotein CD4 Market Segment Percentages, by Type, 2021 (%)
    Forigerimod Acetate
    HIV Vaccine 2
    Ibalizumab
    Others
Global T Cell Surface Glycoprotein CD4 Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)
Global T Cell Surface Glycoprotein CD4 Market Segment Percentages, by Application, 2021 (%)
    HIV
    AIDS
    GVHD
    SARS
    Others
Global T Cell Surface Glycoprotein CD4 Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)
Global T Cell Surface Glycoprotein CD4 Market Segment Percentages, By Region and Country, 2021 (%)
    North America
        US
        Canada
        Mexico
    Europe
        Germany
        France
        U.K.
        Italy
        Russia
        Nordic Countries
        Benelux
        Rest of Europe
    Asia
        China
        Japan
        South Korea
        Southeast Asia
        India
        Rest of Asia
    South America
        Brazil
        Argentina
        Rest of South America
    Middle East & Africa
        Turkey
        Israel
        Saudi Arabia
        UAE
        Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies T Cell Surface Glycoprotein CD4 revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies T Cell Surface Glycoprotein CD4 revenues share in global market, 2021 (%)
Key companies T Cell Surface Glycoprotein CD4 sales in global market, 2017-2022 (Estimated), (K Pcs)
Key companies T Cell Surface Glycoprotein CD4 sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
    Biotest AG
    Bristol-Myers Squibb Co
    CEL-SCI Corp
    Fountain Biopharma Inc
    Immupharma Plc
    Sanofi
    TaiMed Biologics Inc
    United Biomedical Inc
1 Introduction to Research & Analysis Reports
    1.1 T Cell Surface Glycoprotein CD4 Market Definition
    1.2 Market Segments
        1.2.1 Market by Type
        1.2.2 Market by Application
    1.3 Global T Cell Surface Glycoprotein CD4 Market Overview
    1.4 Features & Benefits of This Report
    1.5 Methodology & Sources of Information
        1.5.1 Research Methodology
        1.5.2 Research Process
        1.5.3 Base Year
        1.5.4 Report Assumptions & Caveats
2 Global T Cell Surface Glycoprotein CD4 Overall Market Size
    2.1 Global T Cell Surface Glycoprotein CD4 Market Size: 2021 VS 2028
    2.2 Global T Cell Surface Glycoprotein CD4 Revenue, Prospects & Forecasts: 2017-2028
    2.3 Global T Cell Surface Glycoprotein CD4 Sales: 2017-2028
3 Company Landscape
    3.1 Top T Cell Surface Glycoprotein CD4 Players in Global Market
    3.2 Top Global T Cell Surface Glycoprotein CD4 Companies Ranked by Revenue
    3.3 Global T Cell Surface Glycoprotein CD4 Revenue by Companies
    3.4 Global T Cell Surface Glycoprotein CD4 Sales by Companies
    3.5 Global T Cell Surface Glycoprotein CD4 Price by Manufacturer (2017-2022)
    3.6 Top 3 and Top 5 T Cell Surface Glycoprotein CD4 Companies in Global Market, by Revenue in 2021
    3.7 Global Manufacturers T Cell Surface Glycoprotein CD4 Product Type
    3.8 Tier 1, Tier 2 and Tier 3 T Cell Surface Glycoprotein CD4 Players in Global Market
        3.8.1 List of Global Tier 1 T Cell Surface Glycoprotein CD4 Companies
        3.8.2 List of Global Tier 2 and Tier 3 T Cell Surface Glycoprotein CD4 Companies
4 Sights by Product
    4.1 Overview
        4.1.1 By Type - Global T Cell Surface Glycoprotein CD4 Market Size Markets, 2021 & 2028
        4.1.2 Forigerimod Acetate
        4.1.3 HIV Vaccine 2
        4.1.4 Ibalizumab
        4.1.5 Others
    4.2 By Type - Global T Cell Surface Glycoprotein CD4 Revenue & Forecasts
        4.2.1 By Type - Global T Cell Surface Glycoprotein CD4 Revenue, 2017-2022
        4.2.2 By Type - Global T Cell Surface Glycoprotein CD4 Revenue, 2023-2028
        4.2.3 By Type - Global T Cell Surface Glycoprotein CD4 Revenue Market Share, 2017-2028
    4.3 By Type - Global T Cell Surface Glycoprotein CD4 Sales & Forecasts
        4.3.1 By Type - Global T Cell Surface Glycoprotein CD4 Sales, 2017-2022
        4.3.2 By Type - Global T Cell Surface Glycoprotein CD4 Sales, 2023-2028
        4.3.3 By Type - Global T Cell Surface Glycoprotein CD4 Sales Market Share, 2017-2028
    4.4 By Type - Global T Cell Surface Glycoprotein CD4 Price (Manufacturers Selling Prices), 2017-2028
5 Sights By Application
    5.1 Overview
        5.1.1 By Application - Global T Cell Surface Glycoprotein CD4 Market Size, 2021 & 2028
        5.1.2 HIV
        5.1.3 AIDS
        5.1.4 GVHD
        5.1.5 SARS
        5.1.6 Others
    5.2 By Application - Global T Cell Surface Glycoprotein CD4 Revenue & Forecasts
        5.2.1 By Application - Global T Cell Surface Glycoprotein CD4 Revenue, 2017-2022
        5.2.2 By Application - Global T Cell Surface Glycoprotein CD4 Revenue, 2023-2028
        5.2.3 By Application - Global T Cell Surface Glycoprotein CD4 Revenue Market Share, 2017-2028
    5.3 By Application - Global T Cell Surface Glycoprotein CD4 Sales & Forecasts
        5.3.1 By Application - Global T Cell Surface Glycoprotein CD4 Sales, 2017-2022
        5.3.2 By Application - Global T Cell Surface Glycoprotein CD4 Sales, 2023-2028
        5.3.3 By Application - Global T Cell Surface Glycoprotein CD4 Sales Market Share, 2017-2028
    5.4 By Application - Global T Cell Surface Glycoprotein CD4 Price (Manufacturers Selling Prices), 2017-2028
6 Sights by Region
    6.1 By Region - Global T Cell Surface Glycoprotein CD4 Market Size, 2021 & 2028
    6.2 By Region - Global T Cell Surface Glycoprotein CD4 Revenue & Forecasts
        6.2.1 By Region - Global T Cell Surface Glycoprotein CD4 Revenue, 2017-2022
        6.2.2 By Region - Global T Cell Surface Glycoprotein CD4 Revenue, 2023-2028
        6.2.3 By Region - Global T Cell Surface Glycoprotein CD4 Revenue Market Share, 2017-2028
    6.3 By Region - Global T Cell Surface Glycoprotein CD4 Sales & Forecasts
        6.3.1 By Region - Global T Cell Surface Glycoprotein CD4 Sales, 2017-2022
        6.3.2 By Region - Global T Cell Surface Glycoprotein CD4 Sales, 2023-2028
        6.3.3 By Region - Global T Cell Surface Glycoprotein CD4 Sales Market Share, 2017-2028
    6.4 North America
        6.4.1 By Country - North America T Cell Surface Glycoprotein CD4 Revenue, 2017-2028
        6.4.2 By Country - North America T Cell Surface Glycoprotein CD4 Sales, 2017-2028
        6.4.3 US T Cell Surface Glycoprotein CD4 Market Size, 2017-2028
        6.4.4 Canada T Cell Surface Glycoprotein CD4 Market Size, 2017-2028
        6.4.5 Mexico T Cell Surface Glycoprotein CD4 Market Size, 2017-2028
    6.5 Europe
        6.5.1 By Country - Europe T Cell Surface Glycoprotein CD4 Revenue, 2017-2028
        6.5.2 By Country - Europe T Cell Surface Glycoprotein CD4 Sales, 2017-2028
        6.5.3 Germany T Cell Surface Glycoprotein CD4 Market Size, 2017-2028
        6.5.4 France T Cell Surface Glycoprotein CD4 Market Size, 2017-2028
        6.5.5 U.K. T Cell Surface Glycoprotein CD4 Market Size, 2017-2028
        6.5.6 Italy T Cell Surface Glycoprotein CD4 Market Size, 2017-2028
        6.5.7 Russia T Cell Surface Glycoprotein CD4 Market Size, 2017-2028
        6.5.8 Nordic Countries T Cell Surface Glycoprotein CD4 Market Size, 2017-2028
        6.5.9 Benelux T Cell Surface Glycoprotein CD4 Market Size, 2017-2028
    6.6 Asia
        6.6.1 By Region - Asia T Cell Surface Glycoprotein CD4 Revenue, 2017-2028
        6.6.2 By Region - Asia T Cell Surface Glycoprotein CD4 Sales, 2017-2028
        6.6.3 China T Cell Surface Glycoprotein CD4 Market Size, 2017-2028
        6.6.4 Japan T Cell Surface Glycoprotein CD4 Market Size, 2017-2028
        6.6.5 South Korea T Cell Surface Glycoprotein CD4 Market Size, 2017-2028
        6.6.6 Southeast Asia T Cell Surface Glycoprotein CD4 Market Size, 2017-2028
        6.6.7 India T Cell Surface Glycoprotein CD4 Market Size, 2017-2028
    6.7 South America
        6.7.1 By Country - South America T Cell Surface Glycoprotein CD4 Revenue, 2017-2028
        6.7.2 By Country - South America T Cell Surface Glycoprotein CD4 Sales, 2017-2028
        6.7.3 Brazil T Cell Surface Glycoprotein CD4 Market Size, 2017-2028
        6.7.4 Argentina T Cell Surface Glycoprotein CD4 Market Size, 2017-2028
    6.8 Middle East & Africa
        6.8.1 By Country - Middle East & Africa T Cell Surface Glycoprotein CD4 Revenue, 2017-2028
        6.8.2 By Country - Middle East & Africa T Cell Surface Glycoprotein CD4 Sales, 2017-2028
        6.8.3 Turkey T Cell Surface Glycoprotein CD4 Market Size, 2017-2028
        6.8.4 Israel T Cell Surface Glycoprotein CD4 Market Size, 2017-2028
        6.8.5 Saudi Arabia T Cell Surface Glycoprotein CD4 Market Size, 2017-2028
        6.8.6 UAE T Cell Surface Glycoprotein CD4 Market Size, 2017-2028
7 Manufacturers & Brands Profiles
    7.1 Biotest AG
        7.1.1 Biotest AG Corporate Summary
        7.1.2 Biotest AG Business Overview
        7.1.3 Biotest AG T Cell Surface Glycoprotein CD4 Major Product Offerings
        7.1.4 Biotest AG T Cell Surface Glycoprotein CD4 Sales and Revenue in Global (2017-2022)
        7.1.5 Biotest AG Key News
    7.2 Bristol-Myers Squibb Co
        7.2.1 Bristol-Myers Squibb Co Corporate Summary
        7.2.2 Bristol-Myers Squibb Co Business Overview
        7.2.3 Bristol-Myers Squibb Co T Cell Surface Glycoprotein CD4 Major Product Offerings
        7.2.4 Bristol-Myers Squibb Co T Cell Surface Glycoprotein CD4 Sales and Revenue in Global (2017-2022)
        7.2.5 Bristol-Myers Squibb Co Key News
    7.3 CEL-SCI Corp
        7.3.1 CEL-SCI Corp Corporate Summary
        7.3.2 CEL-SCI Corp Business Overview
        7.3.3 CEL-SCI Corp T Cell Surface Glycoprotein CD4 Major Product Offerings
        7.3.4 CEL-SCI Corp T Cell Surface Glycoprotein CD4 Sales and Revenue in Global (2017-2022)
        7.3.5 CEL-SCI Corp Key News
    7.4 Fountain Biopharma Inc
        7.4.1 Fountain Biopharma Inc Corporate Summary
        7.4.2 Fountain Biopharma Inc Business Overview
        7.4.3 Fountain Biopharma Inc T Cell Surface Glycoprotein CD4 Major Product Offerings
        7.4.4 Fountain Biopharma Inc T Cell Surface Glycoprotein CD4 Sales and Revenue in Global (2017-2022)
        7.4.5 Fountain Biopharma Inc Key News
    7.5 Immupharma Plc
        7.5.1 Immupharma Plc Corporate Summary
        7.5.2 Immupharma Plc Business Overview
        7.5.3 Immupharma Plc T Cell Surface Glycoprotein CD4 Major Product Offerings
        7.5.4 Immupharma Plc T Cell Surface Glycoprotein CD4 Sales and Revenue in Global (2017-2022)
        7.5.5 Immupharma Plc Key News
    7.6 Sanofi
        7.6.1 Sanofi Corporate Summary
        7.6.2 Sanofi Business Overview
        7.6.3 Sanofi T Cell Surface Glycoprotein CD4 Major Product Offerings
        7.6.4 Sanofi T Cell Surface Glycoprotein CD4 Sales and Revenue in Global (2017-2022)
        7.6.5 Sanofi Key News
    7.7 TaiMed Biologics Inc
        7.7.1 TaiMed Biologics Inc Corporate Summary
        7.7.2 TaiMed Biologics Inc Business Overview
        7.7.3 TaiMed Biologics Inc T Cell Surface Glycoprotein CD4 Major Product Offerings
        7.7.4 TaiMed Biologics Inc T Cell Surface Glycoprotein CD4 Sales and Revenue in Global (2017-2022)
        7.7.5 TaiMed Biologics Inc Key News
    7.8 United Biomedical Inc
        7.8.1 United Biomedical Inc Corporate Summary
        7.8.2 United Biomedical Inc Business Overview
        7.8.3 United Biomedical Inc T Cell Surface Glycoprotein CD4 Major Product Offerings
        7.8.4 United Biomedical Inc T Cell Surface Glycoprotein CD4 Sales and Revenue in Global (2017-2022)
        7.8.5 United Biomedical Inc Key News
8 Global T Cell Surface Glycoprotein CD4 Production Capacity, Analysis
    8.1 Global T Cell Surface Glycoprotein CD4 Production Capacity, 2017-2028
    8.2 T Cell Surface Glycoprotein CD4 Production Capacity of Key Manufacturers in Global Market
    8.3 Global T Cell Surface Glycoprotein CD4 Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
    9.1 Market Opportunities & Trends
    9.2 Market Drivers
    9.3 Market Restraints
10 T Cell Surface Glycoprotein CD4 Supply Chain Analysis
    10.1 T Cell Surface Glycoprotein CD4 Industry Value Chain
    10.2 T Cell Surface Glycoprotein CD4 Upstream Market
    10.3 T Cell Surface Glycoprotein CD4 Downstream and Clients
    10.4 Marketing Channels Analysis
        10.4.1 Marketing Channels
        10.4.2 T Cell Surface Glycoprotein CD4 Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
    12.1 Note
    12.2 Examples of Clients
    12.3 Disclaimer

NEED Help?

If you need any help or guidance, please feel free to call us.

USA : +1 (661) 636 6162

INDIA : +91 9325802062

or

Write us on : sales@kandjmarketresearch.com